Detection of telomerase activity in psoriasis lesional skin and correlaton with Ki-67 expression and suppression by retinoic acid

Journal of Korean Medical Science

Volumn 16, Issue 5, 2001, Pages 623-629

  Jang, Ho Sun ^a,b   Oh, Chang Keun ^a   Jo, Ju Hyun ^a   Kim, Yu Sun ^b   Kwon, Kyung Sool ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Hospital   (South Korea)

Author keywords

Cell proliferation; HaCaT Cells; Ki 67 Antigen; Psoriasis; Telomerase; Tretinoin

Indexed keywords

ENZYME INHIBITOR; KI 67 ANTIGEN; RETINOIC ACID; TELOMERASE;

ARTICLE; CELL DIVISION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; PSORIASIS; SKIN;

CELL DIVISION; CELL LINE; ENZYME INHIBITORS; HUMANS; KI-67 ANTIGEN; PSORIASIS; SKIN; TELOMERASE; TRETINOIN;

EID: 0035490537     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.5.623     Document Type: Article

References (30)

1. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-91.
2. Rudolph P, Schubert C, Tamm S, Heidorn K, Hauschild A, Michalska I, Majewski S, Krupp G, Jablonska S, Parwaresch R. Telomerase activity in melanocytic lesions; a potential marker of tumor biology. Am J Pathol 2000; 156: 1425-32.
3. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, Fellows G, Goodison S, Tahara E, Tarin D. Telomerase activity in bladder carcinoma and its implications for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-9.
4. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlation of telomerase activity level with human neuroblastoma outcome. Nature Med 1995; 1: 249-55.
5. Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 1997; 3: 1593-8.
6. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-5.
7. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998; 95: 90-2.
8. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996; 16: 2932-9.
9. Wu K, Volke A, Lund M, Bang K, Thestrup-Pederson K. Telomerase activity is spontaneously increased in lymphocytes from patients with atopic dermatitis and correlates with cellular proliferation. J Dennatol Sci 1999; 22: 24-30.
10. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476-81.
11. Belair CD, Yeager TR, Lopez PM, Reznikoff CA. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997; 94: 13677-82.
12. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 1993; 178: 1271-81.
13. Kallassy M, Martel N, Damour O, Yamasaki H, Nakazawa H. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Mol Carcinog 1998; 21: 26-36.
14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
15. Wright W, Piatyszek M, Rainey W, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996; 18: 173-9.
16. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997; 57; 610-4.
17. Kannan S, Tahara H, Yokozaki H, Mathew B, Nalinakumari KR, Nair MK, Tahara E. Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epiderm Biomarkers Prevent 1997; 6: 413-20.
18. Parris CN, Jezzard S, Silver A, MacKie R, McGregor JM, Newbold RF. Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer 1999; 79: 47-53.
19. Ogoshi M, Le T, Shay JW, Taylor RS. In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol 1998; 110: 818-23.
20. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996; 106: 759-65.
21. Bickenbach JR, Vormawald-Dogan V, Bachor C, Bleuel K, Schanapp G, Boukamp P. Telomerase is not an epidermal stem cell marker and is downregulated by calcium. J Inves Dermatol 1998; 111: 1045-52.
22. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-63.
23. Mokbel K, Parris CN, Ghilchik M, Williams G, Newbold RF. The association between telomerase, histopathological parameters, and Ki-67 expression in breast cancer. Am J Surg 1999; 178: 69-72.
24. Poremba C, Bocker W, Willenbring H, Schafer KL, Otterbach F, Burger H, Diallo R, Dockhorn-Dworniczak B. Telomerase activity in human proliferative breast lesions. Int J Oncol 1998; 12: 641-8.
25. Miracco C, Pacenti L, Santopietro R, Biagioli M, Fimiani M, Perotti R, Rubegni P, Pirtoli L, Luzi P. Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki-67 and expression of cyclins D1 and A in cutaneous melanoma. Int J Cancer 2000; 88: 411-6.
26. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183: 2471-9.
27. Albanell J, Han W, Mellado B, Gunawardane R, Scher HI, Dmitrovsky E, Moore MA. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res 1996; 56: 1503-8.
28. Sharma HW, Sokolonski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 1995; 92: 12343-6.
29. 2+. Differentiation 1993; 54: 201-17.
30. Wanner R, Wolff B, Glowacki F, Kolde G, Wittig B. The loss of desmosomes after retinoic acid treatment results in an apparent inhibition of HaCaT keratinocyte differentiation. Arch Dermatol 1999; 291: 346-53.